Global pharmaceutical company Pfizer (NYSE:PFE) in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the ...

Pfizer (NYSE: PFE) beat earnings expectations decisively this morning, posting adjusted EPS of $0.87 against a $0.64 ...

Pfizer Inc. (NYSE: PFE) today issued the following statement in response to the Delaware Chancery Court’s decision denying ...

After raising its 2025 profit forecast again, Pfizer turns its sights on Novo Nordisk in a billion-dollar obesity drug ...

Pfizer revenue trends remained uneven in the third quarter, the company exhibited "continued cost discipline," according to ...

Analysts expect the health care company to report quarterly earnings at 64 cents per share, down from $1.06 per share in the ...

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer had in this week’s game plan. Cramer discussed the future ...

Novo Nordisk has increased its offer to approximately $10 billion, valuing Metsera at up to $86.20 per share. The revised bid ...

A few years ago, Pfizer (NYSE: PFE) represented the ideal pharmaceutical stock investment. The company, as leader in the coronavirus vaccine and treatment market, offered a great deal of growth, and ...

Pfizer Inc. (NYSE:PFE) is one of the Best Stocks to Buy for High Returns Heading into 2026. On October 27, Berenberg Bank ...

One struggling pharma stock that could use a boost from a strong earnings report is Pfizer (NYSE: PFE). The company's valuation has plummeted in recent years as patent cliffs and ...

US pharma giant Pfizer (NYSE: PFE) reported financial results for the third quarter of 2025 on Tuesday. Revenues for the ...